Global DNA methylation changes in blood of patients with essential hypertension

Medical Science Monitor

Volumn 16, Issue 3, 2010, Pages

  Smolarek, Iwona ^a   Wyszko, Eliza ^b   Barciszewska, Anna M ^a   Nowak, Stanislaw ^a   Gawronska, Iwona ^b   Jablecka, Anna ^a   Barciszewska, Miroslawa Z ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

5 methylcytosine; DNA methylation; Epigenetics; Essential hypertension; Oxidative stress

Indexed keywords

5 METHYLCYTOSINE; DNA; TRIACYLGLYCEROL;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA DETERMINATION; DNA ISOLATION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ANALYSIS; HUMAN; HYDROLYSIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; THIN LAYER CHROMATOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL;

5-METHYLCYTOSINE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, THIN LAYER; DEAMINATION; DNA METHYLATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77649260034     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The World Health Report 2002. Chapter 4: Quantifying selected major risks to health. 2002; 47-97
2. Zimmerman BG, Sybertz EJ, Wong PC: Interaction between sympathetic and renin-angiotensin system. J Hypertens, 1984; 2(6): 581-87
3. Pagliaro P, Penna C: Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther, 2005; 19: 77-87
4. Brunner H, Cockcroft JR, Deanfield J et al: Endothelial function and dysfunction. Part II. Association with cardiovascular risk factors and diseases: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens, 2005; 23: 233-46
5. Luft FC: Geneticism of essential hypertension. Hypertension, 2004; 43: 1155-59
6. Harrap SB, Davidson HR, Connor JM et al: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension, 1993; 21: 455-60
7. Gleibermann L: Blood pressure and dietary salt in human populations. Ecol Food Nutr 1973; 2: 143-156
8. Reaven GM: Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab, 2003; 88: 2399-403
9. Yan LL, Liu K, Matthews KA et al: Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (Cardia) study. JAMA, 2003; 290: 2190-92
10. Groppelli A, Giorgi DM, Omboni S et al: Persistent blood pressure increase induced by heavy smoking. J Hypertens, 1992; 10: 495-99
11. Estruch R, Coca A, Rodicio JL: High blood pressure, alcohol and cardiovascular risk. J Hypertens, 2005; 23: 226-29
12. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene, 2002; 21: 5400-13
13. Ehrlich M: Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem, 2003; 88: 899-910
14. Havlis J, Trbusek M: 5-methylcytosine as a marker for the monitoring of DNA methylation. J Chromatogr, 2002; B781: 373-92
15. Shiraishi M, Oates AJ, Sekiya T: An overview of the analysis of DNA methylation in mammalian genomes. Biol Chem, 2002; 383: 893-906
16. Cox MM: Better chemistry for better survival through regulation. Cell, 2003; 112: 286-87
17. Giles NM, Gutowski NJ, Giles GI, Jacob C: Redox catalysts as sensitisers towards oxidative stress. FEBS Lett, 2003; 535: 179-82
18. Rodenhiser D, Mann M: Epigenetics and human disease: translating basic biology into clinical applications. CMAJ, 2006; 174(3): 341-48
19. Zukiel R, Barciszewska AM, Barciszewska MZ: A simple epigenetic method for the diagnosis and classification of brain tumors. Mol Cancer Res, 2004; 2: 196-202
20. Robertson KD: DNA methylation, methylotransferases, and cancers. Oncogene, 2001; 20: 3139-55
21. Suzuki K, Suzuki I, Leodolter A et al: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell, 2006; 9: 199-207
22. Barciszewska AM, Murawa D, Barciszewska MZ et al: Analysis of 5-methylcytosine in DNA of breast and colon cancer tissues. IUBMB Life, 2007; 59: 765-70
23. Kamiya H, Tsuchiya H, Karino N et al: Mutagenicity of 5-formylcytosine, an oxidation product of 5-methylcytosine in DNA in mammalian cells. J Biochem, 2002; 132: 551-55
24. Fraga MF, Esteller M: DNA methylation: a profile of methods and applications. Biotechniques, 2002; 33: 632-49
25. Castro R, Rivera I, Struys EA et al: Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem, 2003; 49(8): 1292-96
26. Stenvinkel P, Karimi M, Johansson S et al: Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease. J Int Med, 2007; 261: 488-99
27. Oakeley EJ: DNA methylation analysis: a review of current methodologies. Pharmacol Therap, 1999; 84: 389-400
28. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res, 1988; 16: 1215
29. Friedman J, Peleg E, Kagan T et al: Oxidative stress in hypertensive, diabetic, and diabetic hypertensive rats. Am J Hypertens, 2003; 16: 1049-52
30. Droge W: Free radicals in the physiological control of cell function. Physiol Rev, 2002; 82: 47-95
31. Paravicini TM, Touyz RM: Redox signaling in hypertension. Cardiovascular Research, 2006; 71: 247-58
32. Paravicini TM, Chrissobolis S, Drummond GR, Sobey CG: Increased NADPH - Oxidase Activity and Nox4 Expression During Chronic Hypertension Is Associated With Enhanced Cerebral Vasodilatation to NADPH In Vivo. Stroke, 2004; 35: 584-89
33. Kantor B, Razin A: DNA methylation, histone deacetylase repressory complex and development. Gene Func Dis, 2001; 2: 69-75
34. Barciszewska MZ, Barciszewska AM, Rattan SIS: TLC-based detection of methylated cytosine: application to aging epigenetics. Biogerontology, 2007; 8: 673-78
35. Attwood JT, Yung RL, Richardson BC: DNA methylation and the regulation of gene transcription. Cell Mol Life Sci, 2002; 59(2): 241-57
36. Romero AA, Gross SR, Cheng KY et al: An age-related increase in resistance to DNA damage-induced apoptotic cell death is associated with development of DNA repair mechanism. J Neurochem, 2003; 84: 1275-87
37. Cabelof DC, Raffoul JJ, Ge Y et al: Age-related loss of the DNA repair response following exposure to oxidative stress. J Gerontol A Biol Sci Med Sci, 2006; 61(5): 427-34
38. Jackson MB, Osei SY, Ahima RS: The endocrine role of adipose tissue: focus on adiponectin and resistin. Curr Opin Endocrinol Diab, 2005; 12: 163-70
39. Barouch LA, Gao D, Chen L et al: Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res, 2006; 298: 118
40. Lund G, Andersson L, Lauria M et al: DNA Methylation Polymorphisms Precede Any Histological Sign of Atherosclerosis in Mice Lacking Apolipoprotein E. J Biol Chem, 2004; 279(28): 29147-54
41. Laukkanen MO, Mannermaa S, Hiltunen MO et al: Local Hypomethylation in Atherosclerosis Found in Rabbit ec-sod Gen. Arteriosc Thromb Vasc Biol, 1999; 19: 2171-78
42. Valinluck V, Tsai HH, Rogstad DK et al: Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res, 2004; 32: 4100-8